Target intelligence / Profile preview

MicroRNA-4493 (MIR4493)

Target
MIR4493
Molecular classification
MicroRNA, Non-coding RNA, Other (small RNA)
01

Overview

MicroRNA-4493 (MIR4493) is a small, non-coding RNA molecule belonging to the microRNA (miRNA) family. miRNAs are approximately 21–23 nucleotides in length and are key regulators of gene expression at the post-transcriptional level. They typically interact with the 3’ untranslated regions of target mRNAs, resulting in translational inhibition or degradation of the mRNA. While the microRNA family as a whole plays fundamental roles in regulating cell differentiation, proliferation, apoptosis, and other critical biological processes, there is currently no specific functional or disease data available for MIR4493 itself. The study and classification of individual microRNAs, such as MIR4493, contributes to understanding complex gene regulatory networks and may have future implications for diagnostics or therapeutics once their specific roles are better defined[1][3][4][5]. *Note:* The lack of specific data for MIR4493 in disease or drug interaction contexts reflects its limited characterization in current scientific literature. However, its inclusion in the human miRNA repertoire and general mechanistic properties are well established through the broader understanding of microRNAs.

Other names
hsa-mir-4493hsa-miR-4493MIR4493
02

Mechanism of action

MicroRNAs such as MIR4493 exert their function by pairing with complementary sequences on target mRNAs, usually resulting in gene silencing through mRNA degradation or translational repression[1][4][3].

03

Biological functions

Post-transcriptional gene silencingRegulation of gene expressionRNA interference
04

Disease associations

Cancer (general microRNA family involvement; no direct evidence for MIR4493 specifically found in current sources)Other (potential for involvement in various diseases through gene regulation, but no direct validated disease association for MIR4493 found in available data)
05

Safety considerations

Altering microRNA levels systemically may impact multiple gene networks, leading to unpredictable effects and potential off-target toxicity[4].General safety concerns with microRNA therapeutics include delivery efficiency, specificity, and immune stimulation.
06

Biomarkers

MicroRNAs are studied as biomarkers for various diseases, particularly cancers, due to their stability in biofluids and differential expression profiles[5][4].No direct validation of MIR4493 as a biomarker in currently available data.

Beyond the preview

Go deeper on MicroRNA-4493 (MIR4493).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on MicroRNA-4493 (MIR4493).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call